These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2459831)

  • 21. Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared.
    Schifman RB; Ahmann FR; Elvick A; Ahmann M; Coulis K; Brawer MK
    Clin Chem; 1987 Nov; 33(11):2086-8. PubMed ID: 2445507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian and day-to-day variation of prostatic acid phosphatase.
    Nissenkorn I; Mickey DD; Miller DB; Soloway MS
    J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prostatic diseases: tumor markers (PAP and PSA) and age at risk].
    Manna A; Trasatti L; Cifaldi L; Marchei GG; Reale MG; Marchei P
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):91. PubMed ID: 1709213
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice.
    Csapo Z; Brand K; Walther R; Fokas K
    J Urol; 1988 Nov; 140(5):1032-8. PubMed ID: 2459419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of prostate-specific antigen and prostatic acid phosphatase in the management of prostatic cancer.
    Turkes A; Nott J; Turkes AO; Griffiths K
    Am J Clin Oncol; 1988; 11 Suppl 2():S77-9. PubMed ID: 2468280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Discrepancy between the serum levels of gamma seminoprotein and prostate-specific antigen in patients with prostatic neoplasms. Both true or either untrue].
    Fujino A; Mukai N; Kawakami T; Yokoyama E; Mashimo S; Endo T; Ishibashi A; Koshiba K; Aoki Y; Itoh H
    Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):541-50. PubMed ID: 1711133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.
    van Dieijen-Visser MP; Delaere KP; Gijzen AH; Brombacher PJ
    Clin Chim Acta; 1988 May; 174(2):131-40. PubMed ID: 2454767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple marker evaluation in prostatic cancer with prostatic acid phosphatase, gamma-seminoprotein and prostate-specific antigen.
    Fuse H; Umeda K; Mizuno I; Katayama T
    Int Urol Nephrol; 1991; 23(5):455-63. PubMed ID: 1718922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.
    Drago JR; Badalament RA; Wientjes MG; Smith JJ; Nesbitt JA; York JP; Ashton JJ; Neff JC
    Urology; 1989 Oct; 34(4):187-92. PubMed ID: 2477931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum prostate-specific antigen determination in prostatic carcinoma.
    Tizzani A; Casetta G; Piana P; Bellina M; Pecchio F; Aimo G; Adamo R
    Int J Biol Markers; 1987; 2(3):184-6. PubMed ID: 2453594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
    Tarle M
    Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
    Price A; Attwood SE; Grant JB; Gray TA; Moore KT
    Clin Chem; 1991 Jun; 37(6):859-63. PubMed ID: 1710953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
    Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
    Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian variation of different fractions of serum acid phosphatase.
    Schmeller NT; Bauer HW
    Prostate; 1983; 4(4):391-5. PubMed ID: 6191317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of PSA and PAP in patients with or without prostatic cancer.
    Caty A; Gosselin P; Cazin JL; Dehaut JM; Adenis L
    Am J Clin Oncol; 1988; 11 Suppl 2():S63-4. PubMed ID: 2468275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
    Pagani F; Zambolin T; Bonora R; Panteghini M
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):85-7. PubMed ID: 1709211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers.
    Seamonds B; Yang N; Anderson K; Whitaker B; Shaw LM; Bollinger JR
    Urology; 1986 Dec; 28(6):472-9. PubMed ID: 2431533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
    Tarle M
    Anticancer Res; 1988; 8(4):569-72. PubMed ID: 2460018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostate.
    Siddall JK; Cooper EH; Newling DW; Robinson MR; Whelan P
    Eur Urol; 1986; 12(2):123-30. PubMed ID: 2420600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.